Insight Molecular Diagnostics Inc. (IMDX): Free Cash Flow
-$25.37M
Year ended 2025-12-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$25.37M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$21.20M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$23.61M | n/m | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | -$49.91M | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | -$38.19M | n/m | 2023-04-12, From 2021-01-01 |
| 2020-12-31 | -$27.21M | n/m | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | -$20.63M | n/m | 2021-03-19, From 2019-01-01 |
| 2018-12-31 | -$11.68M | n/m | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | -$13.48M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$7.63M | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$4.73M | n/m | 2018-04-02, From 2015-01-01 |
| 2014-12-31 | -$1.17M | n/a | 2017-02-27, From 2014-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$25.37M | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$7.04M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$19.77M | n/m |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | -$213.66M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | $1.22M | n/m |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$9.79M | n/m |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$395.87M | n/m |
| Neogen Corp (NEOG) | 2026-05-31 | $31.90M | n/m |
| Cardio Diagnostics Holdings, Inc. (CDIO) | 2025-12-31 | -$5.91M | n/m |
Compare IMDX, AWHL, VNRX, CLDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗